Scarica l'app Stockscreener
8.18
2.25%
0.18
Dopo l'orario di chiusura:
7.92
-0.26
-3.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Precedente Chiudi:
$8.00
Aprire:
$8
Volume 24 ore:
3.44M
Relative Volume:
2.16
Capitalizzazione di mercato:
$1.30B
Reddito:
$93.95M
Utile/perdita netta:
$-129.87M
Rapporto P/E:
-9.0889
EPS:
-0.9
Flusso di cassa netto:
$-202.88M
1 W Prestazione:
-17.62%
1M Prestazione:
-6.51%
6M Prestazione:
-27.16%
1 anno Prestazione:
+59.77%
Intervallo 1D:
$7.485
$8.20
Intervallo di 1 settimana:
$7.115
$10.06
Portata 52W:
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Nome
Wave Life Sciences Ltd
Settore
Industria
Telefono
617-949-2900
Indirizzo
7 STRAITS VIEW, SINGAPORE
Confronta WVE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.18 | 1.53B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-04 | Iniziato | Canaccord Genuity | Buy |
| 2025-07-28 | Iniziato | Oppenheimer | Outperform |
| 2025-07-16 | Iniziato | Citigroup | Buy |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Iniziato | Wedbush | Outperform |
| 2025-02-25 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Ripresa | JP Morgan | Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-09-09 | Iniziato | JP Morgan | Overweight |
| 2024-05-15 | Iniziato | Wells Fargo | Overweight |
| 2023-12-19 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Iniziato | Raymond James | Outperform |
| 2023-05-24 | Downgrade | Jefferies | Buy → Hold |
| 2020-12-15 | Ripresa | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Iniziato | Guggenheim | Buy |
| 2019-07-15 | Iniziato | Cowen | Market Perform |
| 2019-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2018-08-07 | Iniziato | Stifel | Buy |
| 2018-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2017-02-15 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-07 | Iniziato | Jefferies | Buy |
| 2015-12-07 | Iniziato | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences stock price target lowered to $16 at Jones Trading - Investing.com
Wave Life says data are positive but stock wavers - BioWorld MedTech
Leerink Partners raises WAVE Life Sciences stock price target to $26 on AATD data - Investing.com
Assessing Wave Life Sciences' (WVE) RNA Editing Pipeline: Is the Stock Undervalued Amid Clinical Progress and Financial Challenges? - AInvest
Transcript : Wave Life Sciences Ltd.Special Call - MarketScreener
Using Ichimoku Cloud for Wave Life Sciences Ltd. technicalsTreasury Yields & Daily Market Momentum Tracking - Newser
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? - Benzinga
WVE: HC Wainwright & Co. Reiterates Buy Rating with $22 PT | WVE Stock News - GuruFocus
Wave Life Sciences Shares Drop Following WVE-006 Trial Update - MSN
Wave Life Sciences Says RNA-Editing Therapy Achieves 'Durable' Serum AAT Protein Production - MarketScreener
Why Is Wave Life Sciences Stock (WVE) Down 20% Today? - TipRanks
Wave Life Sciences reports promising data for AATD treatment - Investing.com
Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy (WVE:NASDAQ) - Seeking Alpha
Wave Life Sciences Announces Positive Results for WVE-006 Study - TipRanks
Wave Life Sciences stock tumbles after WVE-006 trial update - Investing.com
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency - The Manila Times
Wave Life Sciences Announces Positive Update from Ongoing - GlobeNewswire
Breakthrough: First-Ever Restored AAT Production of 20.6µM Achieved in Wave's AATD Treatment Trial - Stock Titan
Will Wave Life Sciences Ltd. rebound enough to break evenInsider Selling & Daily Market Momentum Tracking - Newser
Momentum divergence signals in Wave Life Sciences Ltd. chartEarnings Risk Report & Low Risk Profit Maximizing Plans - Newser
How institutional ownership impacts Wave Life Sciences Ltd. stock2025 Historical Comparison & Reliable Price Breakout Signals - Newser
What indicators show strength in Wave Life Sciences Ltd.Earnings Overview Summary & Weekly Watchlist for Consistent Profits - Newser
Wave Life Sciences Ltd. stock daily chart insightsEarnings Risk Report & Fast Gain Stock Tips - Newser
Why Wave Life Sciences Ltd. is moving todayShort Setup & Weekly Chart Analysis and Guides - Newser
Using data tools to time your Wave Life Sciences Ltd. exitJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
Is Wave Life Sciences Ltd.’s ROE strong enough2025 Momentum Check & Advanced Technical Analysis Signals - khodrobank.com
Published on: 2025-09-03 07:48:31 - khodrobank.com
Chart based analysis of Wave Life Sciences Ltd. trendsPrice Action & Free Technical Confirmation Trade Alerts - Newser
Intraday pattern recognizer results for Wave Life Sciences Ltd.July 2025 WrapUp & Fast Gain Stock Tips - Newser
How to build a custom watchlist for Wave Life Sciences Ltd.Wall Street Watch & Safe Capital Growth Tips - Newser
What is the dividend yield of Wave Life Sciences Ltd.July 2025 Macro Moves & Safe Entry Trade Reports - khodrobank.com
How to integrate Wave Life Sciences Ltd. into portfolio analysis toolsExit Point & Risk Controlled Swing Alerts - Newser
Will Wave Life Sciences Ltd. benefit from sector rotationQuarterly Market Summary & Accurate Entry/Exit Alerts - خودرو بانک
Fibonacci Retracement Aligns with Support in Wave Life Sciences Ltd.Portfolio Gains Report & Free Technical Confirmation Trade Alerts - beatles.ru
Wave Life Sciences Ltd. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - thegnnews.com
Published on: 2025-09-01 00:07:21 - Newser
Will earnings trigger a reversal in Wave Life Sciences Ltd.Market Risk Summary & Weekly Momentum Stock Picks - Newser
Real time pattern detection on Wave Life Sciences Ltd. stockWeekly Market Report & Weekly Consistent Profit Watchlists - Newser
Will breakout in Wave Life Sciences Ltd. lead to full recoveryMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Detecting price anomalies in Wave Life Sciences Ltd. with AIWeekly Stock Summary & Consistent Growth Equity Picks - Newser
Can machine learning forecast Wave Life Sciences Ltd. recovery2025 Momentum Check & Real-Time Market Trend Scan - Newser
What does recent volatility data suggest for Wave Life Sciences Ltd.Quarterly Performance Summary & Reliable Price Breakout Signals - Newser
Quant Strategy Flags Wave Life Sciences Ltd. for EntryMarket Risk Analysis & Fast Exit and Entry Trade Guides - beatles.ru
What makes Wave Life Sciences Ltd. stock price move sharplyJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - Newser
Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Wave Life Sciences Ltd Azioni (WVE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BOLNO PAUL | President and CEO |
Aug 22 '25 |
Sale |
10.10 |
217,351 |
2,194,810 |
121,000 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):